Fig. 4.
Adherence to DAAs declines over 12-week treatment course. Adherence between weeks 0–4, 98.1 ± 0.9 %, was significantly higher than adherence between weeks 8–12, 95.0 ± 1.2 %. for patients treated with 12 weeks of LDV/SOF
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.